I agree that this site is using cookies. You can find further informations here.
X
Loirat, D.
689  results:
Search for persons X
?
1

Neoadjuvant pembrolizumab or placebo + chemotherapy, follow..:

Cardoso, F. ; O'Shaughnessy, J. ; McArthur, H....
European Journal of Cancer.  200 (2024)  - p. 113608 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Efficacy of administration sequence: Sacituzumab Govitecan ..:

Poumeaud, F. ; Morisseau, M. ; Cabel, L....
British Journal of Cancer.  , 2024
Link: https://doi.org/10.1038/..
 
?
3

180O IMpassion132 double-blind randomised phase III trial o..:

Dent, R.A. ; André, F. ; Gonçalves, A....
ESMO Open.  9 (2024)  - p. 103202 , 2024
Link: https://doi.org/10.1016/..
 
?
4

IMpassion132 double-blind randomised phase III trial of che..:

Dent, R. ; André, F. ; Gonçalves, A....
Annals of Oncology.  35 (2024)  7 - p. 630-642 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Correction: Alpelisib and fulvestrant in PIK3CA-mutated hor..:

Bello Roufai, D. ; Gonçalves, A. ; De La Motte Rouge, T....
Oncogene.  42 (2023)  17 - p. 1417-1417 , 2023
Link: https://doi.org/10.1038/..
 
?
6

P018 TROPION-Breast03: Datopotamab deruxtecan (Dato-DXd) ± ..:

Bardia, A. ; Pusztai, L. ; Albain, K....
The Breast.  68 (2023)  - p. S23 , 2023
Link: https://doi.org/10.1016/..
 
?
7

A phase I trial of LXS196, a protein kinase C (PKC) inhibit..:

Piperno-Neumann, S. ; Carlino, M. S. ; Boni, V....
British Journal of Cancer.  128 (2023)  6 - p. 1040-1051 , 2023
Link: https://doi.org/10.1038/..
 
?
8

216P Sacituzumab govitecan in metastatic triple-negative br..:

Loirat, D. ; De Moura, A. ; Korbi, S....
ESMO Open.  8 (2023)  1 - p. 101405 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Alpelisib and fulvestrant in PIK3CA-mutated hormone recepto..:

Bello Roufai, D. ; Gonçalves, A. ; De La Motte Rouge, T....
Oncogene.  , 2023
Link: https://doi.org/10.1038/..
 
?
10

189O A phase II study of patritumab deruxtecan (HER3-DXd), ..:

Pistilli, B. ; Ibrahimi, N. ; Lacroix-Triki, M....
ESMO Open.  8 (2023)  1 - p. 101378 , 2023
Link: https://doi.org/10.1016/..
 
?
11

A Therapeutic Challenge: Chemo-refractory Non-metastatic In..:

Loap, P. ; Nicaise, B. ; Laki, F....
Clinical Oncology.  34 (2022)  3 - p. e140 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Concurrent Olaparib with Radiotherapy in Patients with Trip..:

Loap, P. ; Loirat, D. ; Berger, F....
International Journal of Radiation Oncology*Biology*Physics.  114 (2022)  3 - p. S43-S44 , 2022
Link: https://doi.org/10.1016/..
 
?
13

PO-1229 Radiotherapy-based management of non-metastatic Inf..:

Nicaise, B. ; Loap, P. ; Laki, F....
Radiotherapy and Oncology.  170 (2022)  - p. S1037-S1039 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Biomarker analyses in the phase III ASCENT study of sacituz..:

Bardia, A. ; Tolaney, S.M. ; Punie, K....
Annals of Oncology.  32 (2021)  9 - p. 1148-1156 , 2021
Link: https://doi.org/10.1016/..
 
?
15

One-Year Toxicity Report of the RADIOPARP Phase I Trial Eva..:

Loap, P. ; Loirat, D. ; Berger, F....
International Journal of Radiation Oncology*Biology*Physics.  111 (2021)  3 - p. S8 , 2021
Link: https://doi.org/10.1016/..
 
1-15